Oracle Investment Management as of March 31, 2021
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 22 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biohaven Pharmaceutical Holding | 21.5 | $147M | 2.2M | 68.35 | |
| Quidel Corporation | 21.3 | $146M | 1.1M | 127.93 | |
| Aspira Womens Health | 8.5 | $58M | 8.6M | 6.75 | |
| Opko Health (OPK) | 8.0 | $55M | 13M | 4.29 | |
| Pacific Biosciences of California (PACB) | 7.5 | $52M | 1.5M | 33.31 | |
| Dermtech Ord ord (DMTK) | 5.6 | $39M | 761k | 50.79 | |
| Accelr8 Technology | 4.6 | $31M | 3.8M | 8.32 | |
| Agenus Com New (AGEN) | 3.7 | $26M | 9.4M | 2.72 | |
| BioCryst Pharmaceuticals (BCRX) | 3.5 | $24M | 2.4M | 10.17 | |
| Vir Biotechnology (VIR) | 3.5 | $24M | 469k | 51.27 | |
| Amarin Corp Spons Adr New (AMRN) | 1.9 | $13M | 2.1M | 6.21 | |
| Y Mabs Therapeutics (YMAB) | 1.7 | $12M | 381k | 30.24 | |
| Select Medical Holdings Corporation (SEM) | 1.6 | $11M | 325k | 34.10 | |
| Capricor Therapeutics Com New (CAPR) | 1.4 | $9.4M | 2.0M | 4.68 | |
| Codiak Biosciences | 1.2 | $8.2M | 545k | 15.08 | |
| Antares Pharma | 1.1 | $7.8M | 1.9M | 4.11 | |
| Contrafect Corp Com New | 1.1 | $7.5M | 1.6M | 4.80 | |
| Biodesix (BDSX) | 0.7 | $4.8M | 236k | 20.31 | |
| Motus Gi Hldgs Incorporated | 0.7 | $4.5M | 3.7M | 1.21 | |
| Soleno Therapeutics Com New | 0.4 | $2.7M | 2.1M | 1.26 | |
| Forian Ord (FORA) | 0.2 | $1.6M | 155k | 10.11 | |
| Biogen Idec (BIIB) | 0.1 | $675k | 2.4k | 279.85 |
